All News

Regulus Therapeutics treatment reduces HCV replication in the liver.

Patient with ductal carcinoma in situ had a lower risk of all-cause mortality compared with the general population.

The operator of an illegal online pharmacy that distributed narcotics and other prescription medication was sentenced to 8 years in prison.

Although individuals aged 65 years and older face a heighted chance of developing complications from acute respiratory infections, a recent study has indicated that use of vitamin D supplements can help these patients strengthen their immunity against such infections.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

HIV non-disclosure not found to have an adverse impact on depression or anxiety symptoms.

Xyzal, an antihistamine, was previously available only as a prescription medication.

Recommendations for screening, diagnosis, management, and treatment for the specific forms are also included in the position paper.

In an investigation led by the Long Island drug diversion unit of the Drug Enforcement Administration (DEA), Troyan was found to be responsible for distributing more than 70,000 pills over the course of 4 years.

Sanofi announced today that the FDA has approved its 24-hour formulation of levocetirizine dihydrochloride (Xyzal Allergy 24HR) for the over-the-counter (OTC) treatment of symptoms associated with seasonal and year-round allergies.

More than half of Americans take multivitamin/mineral (MVM) supplements containing more than 9 micronutrients (vitamins/minerals) that provide 100% of the recommended daily allowances.

Streptococcus pneumonia is an indiscriminate killer.

Neti pots have become popular for the treatment of sinus congestion, colds, allergies, and moistening nasal passages.

In an increasingly diverse country, our pharmacy profession's ability to educate a diverse workforce may determine our impact.

Rosacea is a chronic skin condition characterized by transient or persistent erythema of the central face including inflammatory papules or pustules, telangiectasia, or hyperplasia of the connective tissue.1 At least 14 million people in the United States have rosacea, and the prevalence may be as high as 5%.1,2 This disease is most common in women (especially during menopause), people with fair skin, and in adults between the ages of 30 and 60.2

The FDA recently approved Endo International and Par Pharmaceutical’s new drug application for its 50 mg/ml ephedrine sulfate injection.

The FDA has approved Teva’s newest asthma treatment for adolescent and adult patients.

Risk factor may serve as a future drug target for ulcerative colitis.

Republican lawmakers may face numerous challenges in repealing the Affordable Care Act.

Availability of new therapies and cost concerns create barriers for cancer patients.

Three studies presented at the European Cancer Congress highlight the need for cancer drug cost reform.

Both RespiClick inhalers were observed to improve lung function in patients with asthma.

Findings may lead to increased survival in patients with glioblastoma.

A new partnership between academia and pharmaceutical industries aims to improve diabetes treatment.

PHLDB3 inhibits the p53 protein to promote tumor growth.

Ophthalmologists may now order the Lucentis 0.5-mg prefilled syringe.

Study estimates 27% of men avoided an unnecessary biopsy for prostate cancer when given an MRI scan first.

Top news of the day from across the health care landscape.